These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 30365141)
1. Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer. Tang Y; Wu B; Huang S; Peng X; Li X; Huang X; Zhou W; Xie P; He P Oncol Rep; 2019 Jan; 41(1):57-66. PubMed ID: 30365141 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer. Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858 [TBL] [Abstract][Full Text] [Related]
3. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone. Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer. Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling. Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541 [TBL] [Abstract][Full Text] [Related]
6. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. Peng X; Guo W; Liu T; Wang X; Tu X; Xiong D; Chen S; Lai Y; Du H; Chen G; Liu G; Tang Y; Huang S; Zou X PLoS One; 2011; 6(5):e20341. PubMed ID: 21647377 [TBL] [Abstract][Full Text] [Related]
7. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway. Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑106b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer. Yin W; Chen J; Wang G; Zhang D Mol Med Rep; 2019 Aug; 20(2):951-958. PubMed ID: 31173237 [TBL] [Abstract][Full Text] [Related]
9. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715 [TBL] [Abstract][Full Text] [Related]
10. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer. Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase. Fu Q; Liu X; Liu Y; Yang J; Lv G; Dong S Int J Mol Med; 2015 Nov; 36(5):1417-25. PubMed ID: 26647850 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1. Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668 [TBL] [Abstract][Full Text] [Related]
13. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling. Li Q; Ye L; Zhang X; Wang M; Lin C; Huang S; Guo W; Lai Y; Du H; Li J; Song L; Peng X Cancer Lett; 2017 Aug; 402():166-176. PubMed ID: 28602974 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446 [TBL] [Abstract][Full Text] [Related]
15. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887 [TBL] [Abstract][Full Text] [Related]
16. miR-539 inhibits prostate cancer progression by directly targeting SPAG5. Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000 [TBL] [Abstract][Full Text] [Related]
17. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145. Guo W; Ren D; Chen X; Tu X; Huang S; Wang M; Song L; Zou X; Peng X J Cell Biochem; 2013 Jul; 114(7):1606-15. PubMed ID: 23355420 [TBL] [Abstract][Full Text] [Related]
18. The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2. Zhou Y; Ji Z; Yan W; Zhou Z; Li H Oncol Rep; 2017 Sep; 38(3):1411-1419. PubMed ID: 28713997 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5. Fan J; Du W; Zhang H; Wang Y; Li K; Meng Y; Wang J FEBS Lett; 2020 Feb; 594(3):466-476. PubMed ID: 31562641 [TBL] [Abstract][Full Text] [Related]
20. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]